Keyword Analysis & Research: arena pharmaceuticals
Keyword Research: People who searched arena pharmaceuticals also searched
Search Results related to arena pharmaceuticals on Search Engine
-
Pfizer Completes Acquisition of Arena Pharmaceuticals
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-arena-pharmaceuticals
WEBMar 11, 2022 · Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases including ulcerative ...
DA: 75 PA: 36 MOZ Rank: 84
-
Pfizer to acquire Arena Pharmaceuticals in $6.7 billion deal - CNBC
https://www.cnbc.com/2021/12/13/pfizer-to-acquire-arena-pharmaceuticals-in-6point7-billion-deal-.html
WEBDec 13, 2021 · Key Points. Pfizer said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach...
DA: 17 PA: 27 MOZ Rank: 80
-
Arena Pharmaceuticals - Wikipedia
https://en.wikipedia.org/wiki/Arena_Pharmaceuticals
WEBArena Pharmaceuticals Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. Arena focused on discovering drugs that act on G protein-coupled receptors (GPCRs). The company developed technology it called Constitutively Activated Receptor Technology (CART) that identified drug leads targeting ...
DA: 58 PA: 70 MOZ Rank: 50
-
Pfizer to Acquire Arena Pharmaceuticals | Pfizer
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-acquire-arena-pharmaceuticals
WEBDec 13, 2021 · Pfizer to Acquire Arena Pharmaceuticals. Proposed acquisition offerspotentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases. Expands innovative pipeline potentially enhancing growth through 2025 and beyond. Transaction valued at $100 per …
DA: 40 PA: 25 MOZ Rank: 58
-
Arena, completing its turnaround, sells to Pfizer for nearly $7 …
https://www.biopharmadive.com/news/pfizer-acquires-arena-pharmaceuticals-inflammation-drugs/611383/
WEBDec 13, 2021 · Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio of inflammation drugs. Pfizer will buy Arena for $100 per share in cash, more than double the biotech’s closing price on Friday.
DA: 43 PA: 9 MOZ Rank: 45
-
Pfizer to Acquire Arena Pharmaceuticals | Business Wire
https://www.businesswire.com/news/home/20211213005204/en/Pfizer-to-Acquire-Arena-Pharmaceuticals
WEBDec 13, 2021 · NEW YORK & PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement...
DA: 69 PA: 17 MOZ Rank: 33
-
Pfizer bets on Arena's promising bowel disease treatment in …
https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13/
WEBDec 13 (Reuters) - Pfizer Inc (PFE.N) said on Monday it would buy drug developer Arena Pharmaceuticals Inc (ARNA.O) for $6.7 billion in cash, to add a promising treatment candidate that targets ...
DA: 45 PA: 26 MOZ Rank: 8
-
Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal
https://www.wsj.com/articles/pfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813
WEBDec 13, 2021 · Pfizer Inc. agreed to acquire Arena Pharmaceuticals Inc. for $6.7 billion, bolstering the pharmaceutical giant’s pipeline of medicines for inflammatory bowel diseases. Pfizer will pay Arena...
DA: 66 PA: 90 MOZ Rank: 87
-
Pfizer to Buy Arena at 100% Premium in $6.7 Billion Deal - Bloomberg.com
https://www.bloomberg.com/news/articles/2021-12-13/pfizer-to-acquire-arena-in-deal-valued-at-6-7-billion
WEBDec 13, 2021 · Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno-inflammatory diseases.
DA: 90 PA: 71 MOZ Rank: 60
-
Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn
https://www.pharmaceutical-technology.com/news/pfizer-arena-pharmaceuticals-acquisition/
WEBMar 14, 2022 · Pfizer has concluded the takeover of the complete outstanding shares, options and restricted stock units of clinical-stage firm Arena Pharmaceuticals for an equity price of nearly $6.7bn or $100 for each share in cash. In December last year, Pfizer entered a definitive agreement to acquire Arena.
DA: 29 PA: 85 MOZ Rank: 26